Stryker Co. (NYSE:SYK) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Stryker Co. (NYSE:SYK) have earned a consensus rating of “Moderate Buy” from the twenty research firms that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and sixteen have given a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $421.90.

A number of research analysts have issued reports on SYK shares. Argus set a $450.00 target price on Stryker in a research note on Monday, February 3rd. JMP Securities reiterated a “market perform” rating on shares of Stryker in a research report on Tuesday, February 18th. Royal Bank of Canada raised their target price on shares of Stryker from $425.00 to $435.00 and gave the stock an “outperform” rating in a report on Wednesday, January 29th. StockNews.com cut shares of Stryker from a “buy” rating to a “hold” rating in a report on Thursday, March 6th. Finally, Truist Financial boosted their price objective on shares of Stryker from $409.00 to $413.00 and gave the company a “hold” rating in a research report on Thursday, January 30th.

Stryker Stock Performance

Shares of SYK stock opened at $373.69 on Friday. The stock has a 50-day moving average of $384.18 and a 200-day moving average of $373.85. Stryker has a one year low of $314.93 and a one year high of $406.19. The stock has a market cap of $142.59 billion, a PE ratio of 48.16, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period last year, the firm earned $3.46 EPS. As a group, sell-side analysts expect that Stryker will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.90%. Stryker’s dividend payout ratio is presently 43.30%.

Insider Buying and Selling

In other news, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Institutional Trading of Stryker

Several hedge funds and other institutional investors have recently modified their holdings of the stock. M1 Capital Management LLC bought a new stake in shares of Stryker during the fourth quarter worth approximately $247,000. 111 Capital acquired a new stake in Stryker during the 4th quarter worth approximately $415,000. NorthCrest Asset Manangement LLC boosted its stake in Stryker by 0.7% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 49,884 shares of the medical technology company’s stock valued at $17,961,000 after purchasing an additional 351 shares during the period. Members Wealth LLC bought a new position in Stryker during the 4th quarter worth $1,143,000. Finally, PKO Investment Management Joint Stock Co acquired a new stake in shares of Stryker during the fourth quarter worth $1,080,000. Institutional investors own 77.09% of the company’s stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.